Feedback

Prof. Gaikwad Anil Bhanudas

Professor, Department of Pharmacy,
BITS Pilani, Pilani Campus

Pharmacology
Department of Pharmacy, Birla Institute of Technology & Science, Pilani- 333031, Rajasthan. India.

Lab members

 

Post-Doctoral Fellow

#NameThesis Title Year startedFunding
1Dr. Vigneshwaran PitchaimaniAlternate day fasting resembles recurrent insulin-induced hypoglycemia model in ratApril 2018 to March 2020SERB-NPDF
2Dr. Vivek AkhouriInterdisciplinary life science programme for advanced research and education in epigenetics and genome editing29 August 2022DBT-BUILDER

Ph.D. Students

S.NoNameThesis TitleYear startedStatus
1
Mr. Almesh Kadakol
(Supervisor)  
Role of angiotensin II on vascular epigenetics in the development of atherosclerosis and therapeutic intervention of esculetin under type 2 diabetic conditions associated with renal failureFeb 2013Completed on 23rd April 2018
2
Mr. Santosh Kumar Goru (Supervisor)  
Role of histone ubiquitination and ACE2 activation in the progression of renal fibrosis in type I diabetic kidneyJan 2014Completed on 9th Jan 2018
3
Ms. Anuradha Pandey 
(Supervisor)  
Role of epigenetics in modulating inflammatory response mediated by NF-kB through AT1 or AT2 receptor in the development of renal failure under type II diabetic conditionJan 2014Completed on 21st  March 2018
4
Mr. Malek Vajir
(Supervisor)  
Role of neprilysin in the development of cardiovascular and renal complications associated with type 1 diabetes.Jan 2015
Completed on 5th Feb 2020
5
Ms. Nisha Sharm
(Supervisor)   
Involvement of Histone H3 Methylation, Angiotensin converting enzyme 2, and Angiotensin II type 2 receptor in the pathogenesis of acute kidney injury under type 1 diabetic and non-diabetic conditionsJan 2016Completed on 22nd  October 2020
6
Mr. Himanshu Sankrityayan (Supervisor)  
Understanding the role and regulation of endoplasmic stress in the development of endothelial dysfunction and kidney disease under type 1 diabetic conditionJuly 2018Completed on 27th September 2022
7
Mr. Prabhjeet Singh
(Co-supervisor) 
Actively targeted nano-carrier system for the co-delivery of temozolomide and an autophagy modulator for the treatment of glioblastoma multiformeDec 2019Work in pogress
8
Mr. Ajinath Kale
(Supervisor)           
Klotho regulation as a novel therapeutic strategy against acute kidney injury-diabetes comorbidity Jan  2020Completed on 4th August 2023
Mr. Vishwadeep Shelke 
(Supervisor) 
Inflammation Targeted Pharmacotherapy for Diabetic Acute Kidney Injury: Exploring Novel CombinationsOct 2020Thesis Submitted on 24th April 2024
10Ms. Ankita Sharma
(Co-supervisor)
Understanding hyperglycemia-induced epigenetic alterations contributing to drug resistance and progression of human pancreatic cancerDec 2020Work in progress
 
11
Ms. Neha Dagar 
(Supervisor)  
Evaluating the role and putative mechanisms of selected nutraceuticals against acute kidney injury under diabetic condition based on network pharmacology approach and experimental validationSept 2021Work in progress
12
Ms. Shikha Thakur
(Co-Supervisor)  
Design, spynthesis, and biological evaluation of Angiotensin II type 1 receptor (AT1R) – neprilysin (NEP) inhibitors (ARNi) against diabetic cardiomyopathy (DCM)Sept 2021 Work in progress

 

 

M. Pharm Students

S.NoNameThesis titleYear
1Mr. Jaspreet SinghTo evaluate the hepatoprotective and hepatocurative activity of Punica Granatum peels2013
2Mr. Virendra SinghLife Saving Potential of NMD 04 Intravenous Fluid Against Animal Models of Hemorrhagic Shock2013
3Mr. Vishakh PrabhkarBiological clock and Parkinsonism: Influence of the neurohormone, melatonin on experimental model of Parkinson’s disease (Co-supervisor)2014
4Mr. Shreyash BagalTo study the expression of angiotensin – II (AT1 & AT2) receptors, oxidative stress and fibrotic markers in the aorta of type II diabetic rats.2015
5Ms. Vibha KumariTo study the different animal models for AKI2018
6Ms. Jyotima MishraRole PARP inhibitors in Fibrosis2018
7Ms. Niharika ShivaSimultaneous activation of ACE2 and ER stress inhibition in the development of type 1 diabetic cardiomyopathy2020
8Ms. Pooja Dhileepkumar Rao
Role of ER stress inhibition and ACE2 activation in endothelial dysfunction under hyperglycemic condition
2020
9Mr. Tahib HabshiEvaluating the renoprotective role of hinokitiol against acute kidney injury under diabetic condition2023

 

B. Pharm Students

S.NoNameThesis/Project titleYear
1Mr. Monil ThakkarcGMP for Phase I Investigational Drugs2011
2Ms. Masuma HasanGood manufacturing practices For processing of mesenchymal Stromal cells2011
3Ms. Anjana RamnathCurrent Good Manufacturing Practices for Positron Emission Tomography Drugs2011
4Mr. Karthik GangavarapuThe Cure: Developing an interactive decision tree builder for breast cancer survival prediction. (Co-supervisor)2014
5Ms. GarimaPartial Parallelization of de novo genome assembler. (Co-supervisor)2015
6Mr. Priyank RajRole of Epigenetics in the development of liver dysfunction under Type II Diabetic conditions2016
7Ms. AnanyaRole hyperglycemia in kidney injury2017
8Mr. Lakshya SharmaThe preclinical and clinical status of Klotho: A review of its therapeutic potential in acute and chronic kidney diseases2023

 

Research practice students

S.NoNameThesis/Project titleYear
1Ms. Anshima SharmaClinical outcomes of SGLT2 inhibitors alone and in combination with existing antidiabetic and cardiovascular therapies: an update2021
2Mr. Uma MaheshEpigenetic regulation of ER stress and autophagy in kidney disease2021
3Ms. Anjana S.Herbal medicine-the future of diabetic nephropathy treatment2021
4Mr. Tahib HabshiRole of endoplasmic reticulum stress and autophagy in acute kidney injury to chronic kidney disease transition2022
5Ms. Tathamika SenNovel promising therapeutic targets for kidney diseases: Emphasis on kidney-specific proteins2022
6Ms. Soumya SikkaRole of lncRNAs in the regulation of ER stress in AKI/Kidney diseases2022
7Mr. Vinayak YelgondeEpigenetic regulation of organelle dynamics in kidney diseases2022
8Ms. Swati MishraImmunosuppression in AKI: What to prefer or to avoid2023
9Mr. Mayur ChandananiFuture therapeutics and biomarkers for diabetic kidney disease: A clinical review2023
10Ms. Shruti ShreyaFuture therapeutics for type 1 diabetes: A clinical review2023
11Ms. Shubhangi SaxenaUnveiling the therapeutic potential of metabolic reprogramming targeted therapies in kidney diseases2023